Andreasson, U <br/><br/>
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.  [electronic resource] 

 -  Molecular psychiatry  Feb 2014 
 - 148-9 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5578 
<br/><br/><label>Standard No.: </label>10.1038/mp.2013.18  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--cerebrospinal fluid<br/>Amyloid beta-Peptides--cerebrospinal fluid<br/>Apolipoprotein E4--genetics<br/>Biomarkers--cerebrospinal fluid<br/>Cognitive Dysfunction--cerebrospinal fluid<br/>Follow-Up Studies<br/>Heterozygote<br/>Humans<br/>Odds Ratio<br/>Peptide Fragments--cerebrospinal fluid<br/>Phosphorylation<br/>tau Proteins--cerebrospinal fluid